• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用哥伦比亚大学量表评估阿尔茨海默病中的精神病理学。

Use of the Columbia University Scale to assess psychopathology in Alzheimer's disease.

作者信息

Devanand D P

机构信息

Memory Disorders Clinic, New York State Psychiatric Institute, NY 10032, USA.

出版信息

Int Psychogeriatr. 1997;9 Suppl 1:137-42; discussion 143-50. doi: 10.1017/s104161029700481x.

DOI:10.1017/s104161029700481x
PMID:9447437
Abstract

The Columbia University Scale for Psychopathology in Alzheimer's disease (CUSPAD) was developed as a short, semistructured instrument that can be administered by a clinician or trained lay interviewer to the relatives or caregivers of patients with probable Alzheimer's disease (AD). The components of the scale focus on symptoms of psychosis, behavioral disturbance, and depression. A simple decision-tree approach is used to identify the presence of specific psychotic features and makes it possible for the instrument to be used by trained lay interviewers. Interrater reliability has been established. Use of this scale in a multicenter longitudinal study of patients with mild to moderate AD revealed that agitation was the most common and persistent symptom, depressed mood with vegetative signs was the least common and least persistent, and paranoid delusions and hallucinations showed moderate persistence over time. Besides its established psychometric properties, the strengths of the CUSPAD include its brevity, clarity in assessing psychotic symptoms, and ease of administration. These features make it useful for cross-sectional and longitudinal evaluation of the symptoms of psychopathology in AD. The main disadvantage is the lack of quantitative ratings of severity for many of the components, making it unsuitable for use in psychopharmacologic trials.

摘要

哥伦比亚大学阿尔茨海默病精神病理学量表(CUSPAD)是作为一种简短的半结构化工具开发的,临床医生或经过培训的非专业访谈者可对可能患有阿尔茨海默病(AD)患者的亲属或照料者进行施测。该量表的组成部分聚焦于精神病性症状、行为障碍和抑郁症状。采用一种简单的决策树方法来识别特定的精神病性特征,使得经过培训的非专业访谈者也能够使用该工具。已经建立了评分者间信度。在一项针对轻至中度AD患者的多中心纵向研究中使用该量表发现,激越为最常见且持续存在的症状,伴有躯体症状的抑郁情绪最不常见且持续时间最短,偏执妄想和幻觉随时间推移呈现中度持续性。除了已确定的心理测量学特性外,CUSPAD的优点还包括其简短性、评估精神病性症状时的清晰度以及易于施测。这些特性使其对于AD精神病理学症状的横断面和纵向评估很有用。主要缺点是许多组成部分缺乏严重程度的定量评分,这使其不适用于精神药理学试验。

相似文献

1
Use of the Columbia University Scale to assess psychopathology in Alzheimer's disease.使用哥伦比亚大学量表评估阿尔茨海默病中的精神病理学。
Int Psychogeriatr. 1997;9 Suppl 1:137-42; discussion 143-50. doi: 10.1017/s104161029700481x.
2
The course of psychopathologic features in mild to moderate Alzheimer disease.轻度至中度阿尔茨海默病的精神病理特征病程
Arch Gen Psychiatry. 1997 Mar;54(3):257-63. doi: 10.1001/archpsyc.1997.01830150083012.
3
The Columbia University Scale for Psychopathology in Alzheimer's disease.哥伦比亚大学阿尔茨海默病精神病理学量表
Arch Neurol. 1992 Apr;49(4):371-6. doi: 10.1001/archneur.1992.00530280051022.
4
The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease.阿尔茨海默病中精神病、行为障碍和抑郁之间的相互关系。
Alzheimer Dis Assoc Disord. 1999 Nov;13 Suppl 2:S3-8.
5
Psychopathological features in Alzheimer's disease: course and relationship with cognitive status.阿尔茨海默病的精神病理学特征:病程及其与认知状态的关系。
J Am Geriatr Soc. 2003 Jul;51(7):953-60. doi: 10.1046/j.1365-2389.2003.51308.x.
6
The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.阿尔茨海默病注册协会痴呆行为评定量表。阿尔茨海默病注册协会行为病理学委员会。
Am J Psychiatry. 1995 Sep;152(9):1349-57. doi: 10.1176/ajp.152.9.1349.
7
Manchester and Oxford University Scale for the psychopathological assessment of dementia.曼彻斯特和牛津大学痴呆症心理病理学评估量表
Int Psychogeriatr. 1997;9 Suppl 1:131-6; discussion 143-50.
8
A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.对可能患有阿尔茨海默病的行为和心理症状的纵向评估。
Int J Geriatr Psychiatry. 2002 Oct;17(10):968-73. doi: 10.1002/gps.736.
9
Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease.台湾阿尔茨海默病患者的行为障碍及照料者的反应
Int Psychogeriatr. 2001 Mar;13(1):121-8. doi: 10.1017/s1041610201007517.
10
Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability.在阿尔茨海默病行为病理评定量表中增加频率加权分数:BEHAVE-AD-FW:方法与信度
Eur Psychiatry. 2001 Jan;16 Suppl 1:5s-24s. doi: 10.1016/s0924-9338(00)00524-1.

引用本文的文献

1
Neuropsychiatric Symptoms and Trajectories of Dependence and Cognition in a Sample of Community-dwelling Older Adults with Dementia.社区居住的老年痴呆症患者的神经精神症状与依赖和认知轨迹。
Curr Alzheimer Res. 2023;20(6):409-419. doi: 10.2174/1567205020666230908163414.
2
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.临床和病理确诊的路易体痴呆和阿尔茨海默病患者生命最后五年的费用。
J Alzheimers Dis. 2023;92(2):457-466. doi: 10.3233/JAD-221021.
3
Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders.
区分冷漠和抑郁:综述神经认知障碍中冷漠和抑郁的行为、神经解剖和治疗相关方面的区别。
Int J Geriatr Psychiatry. 2023 Feb;38(2):e5882. doi: 10.1002/gps.5882.
4
Clinical Trajectories at the End of Life in Autopsy-Confirmed Dementia Patients With Alzheimer Disease and Lewy Bodies Pathologies.尸检确诊阿尔茨海默病和路易体病理患者生命终末期的临床轨迹。
Neurology. 2022 May 24;98(21):e2140-e2149. doi: 10.1212/WNL.0000000000200259. Epub 2022 Apr 4.
5
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology.阿尔茨海默病生物标志物联盟-唐氏综合征:原理与方法
Alzheimers Dement (Amst). 2020 Aug 3;12(1):e12065. doi: 10.1002/dad2.12065. eCollection 2020.
6
Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome.唐氏综合征成人早期阿尔茨海默病痴呆有前景的预后指标。
Alzheimers Dement (Amst). 2020 Jul 5;12(1):e12044. doi: 10.1002/dad2.12044. eCollection 2020.